ISMP Medication Safety Self Assessment for High-Alert Medications

PUBLISHED: Oct 12, 2017
Relevant to: Ambulatory Care, Critical Access Hospitals, Hospitals, Long Term Care, Medical Office/Clinic, Pharmacies

The Institute for Safe Medication Practices (ISMP) has released a new tool to help hospitals, long-term care facilities, and certain outpatient facilities evaluate their best practices related to high-alert medications, identifying opportunities for improvement, and tracking their experiences over time. The ISMP Medication Safety Self Assessment® for High-Alert Medications focuses on general high-alert medications and 11 specific medication categories including:

  • Opioids
  • Insulin
  • Neuromuscular blocking agents
  • Chemotherapy
  • Moderate and minimal sedation

Users of this new tool are able to submit assessment findings to ISMP anonymously via a secure internet portal and will obtain weighted scores so they can compare themselves to demographically similar organizations.

Want to read the full alert and receive alert emails?

Browse Additional Alerts